News Focus
News Focus
icon url

plexrec

10/25/23 4:36 PM

#437000 RE: nidan7500 #436998

" Will they be compelled to move or just"--not really concerned what BP is up to at this point--my main wish-concern--get very positive Excellence and AD data--after that let the games (with BP) begin--give us that "can't beat " hand--4 aces--which I am expecting !!!!! WGT !!!!
icon url

Gambit53

10/25/23 4:56 PM

#437008 RE: nidan7500 #436998

My feeling is one of them will make a move to buyout the company before the price skyrockets, but others will bid as well. Imagine being left in the dust on Alzheimer’s (not to mention all other CNS indications)after spending billions on research. They all hate it when it doesn’t come from in house, but they have no choice here. I always thought 3-71 was the key and I believe that’s absolutely the case now.
icon url

Steady_T

10/25/23 9:58 PM

#437053 RE: nidan7500 #436998

Missling has made it clear no partnership until approval for AD.

Are there conversations going on? Missling has said that there have been multiple companies reach out to Anavex so it seems clear to me that conversations are going on. Missling has positioned Anavex to be able to SIGN a deal on its terms when it wants to.

Any buy out would be a hostile takeover and Missling has positioned strong defenses to prevent that. Missling knows what Anavex has and the potential the company has to become a big player. I think he wants to see that develop. That is his path to becoming a Billionaire.
icon url

Ortiz

10/25/23 10:43 PM

#437060 RE: nidan7500 #436998

“What thoughts does the collective MB have on the possibilities of either partnering or BIGGER PARTNERS B/O sniffing around now that some of the cat is sticking out of the bag?”

Partnering and buyout possibilities are closer than we would like to think, IMO. However, we just got a little more expensive, complicating negotiations for a proper value. Each study that appears to validate MOA and potential future indication adds a substantial amount of value to the company that is yet to be reflected in MC. IMO.

This reviewed paper further proves to me, and possibly to potentially interested parties, why Anavex is worth more than what they may be offering. So, they may be back to the negotiating table to hammer out the details. IMO.

Thanks for your previous reply.